Navigation Links
Cell mechanics may hold key to how cancer spreads and recurs
Date:8/7/2014

CHAMPAIGN, Ill. Cancer cells that break away from tumors to go looking for a new home may prefer to settle into a soft bed, according to new findings from researchers at the University of Illinois.

Some particularly enterprising cancer cells can cause a cancer to spread to other organs, called metastasis, or evade treatment to resurface after a patient is thought to be in remission. The Illinois team, along with colleagues in China, found that these so-called tumor-repopulating cells may lurk quietly in stiffer cellular environments, but thrive in a softer space. The results appear in the journal Nature Communications.

"What causes relapse is not clear," said study leader Ning Wang. Wang is the Leonard C. and Mary Lou Hoeft Professor in Engineering and professor of mechanical science and engineering of the U. of I. "Why are there a few cells left that can come back stronger? We thought cancer cells may have some properties in common with stem cells, which allows them to metastasize to different tissues. Normally, if you take a liver cell and put it in your lung, it will die. But an undifferentiated cell will live."

Two years ago, Wang's group published a method for selecting tumor-repopulating cells (TRCs) from a culture. Thanks to this selection method, the researchers isolated and studied TRCs from melanoma, an aggressive skin cancer notorious for spreading and recurring, to see how the mechanical environment around the cells affected their ability to multiply and cause new tumors.

The researchers grew the cells on gels of different stiffnesses some very soft and some more firm, to mimic different types of tissues in the body. What they found surprised them.

The TRCs placed in very soft gels grew and multiplied, as expected. The cells placed on stiffer gels did not proliferate; however, they did not die, either they became dormant. When the researchers later transferred the dormant TRCs to a soft gel, the cells "woke up" and began to multiply and spread.

Wang speculates that these properties of dormancy and reawakening when the mechanical environment is more inviting may explain why soft tissues, such as the brain or lungs, are most vulnerable to metastasis.

"We have many different types of organs where solid tumors originate, but if you look at the metastasized sites, the majority are in soft tissues," said Wang. "Brain, lung, liver and bone marrow, all soft. So it may not be coincidence. We need to do more research."

Next, Wang and colleagues hope to tackle the question of what makes TRCs so resistant to drugs, a trait that makes recurrent cancer much harder to treat. Unlocking this puzzle may help doctors fight recurrent cancer, although Wang hopes that understanding how TRCs work can lead to treatments that prevent metastasis in the first place.

"The key issue in this paper is outlining the mechanisms that control how TRCs proliferate," Wang said. "The importance of knowing these mechanisms is that we now have targets that we didn't have before, specific targets for new types of drugs that will interfere with this renewal pathway. It could give us a new avenue for treatment and preventing relapse."


'/>"/>
Contact: Liz Ahlberg
eahlberg@illinois.edu
217-244-1073
University of Illinois at Urbana-Champaign
Source:Eurekalert

Related medicine news :

1. Sharp Rise in Risk With New Breast Cancer Gene, Scientists Say
2. NuvOx Pharma Begins Clinical Trial to Treat Brain Cancer
3. Gut microbiome analysis improved noninvasive colorectal cancer screening
4. Young Cancer Patients at Loma Linda University Children's Hospital Treated to an Afternoon of Fun with UCLA Football Players, Sponsored by Stater Bros
5. Gene increases risk of breast cancer to 1 in 3 by age 70
6. Daily Aspirin May Help Prevent Cancer, Study Shows
7. Cancer Diagnostics Universe Discussed in Comprehensive VPG Research Study Published at MarketPublishers.com
8. One in 10 Cancer Survivors Still Smoke Years Later, Study Finds
9. Study shows low uptake of colorectal cancer screening by African Americans in a Veterans Affairs healthcare network
10. Allegheny Health Network Team Develops Biomarker for Early Detection of Esophageal Cancer
11. Study: Many cancer survivors smoke years after diagnosis
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2016)... ... June 24, 2016 , ... ... feeding the Frederick area economy by obtaining investment capital for emerging technology companies. ... 2½ years that have already resulted in more than a million dollars of ...
(Date:6/24/2016)... ... June 24, 2016 , ... Finally, a bruise cream that really ... cream can be incorporated into the post-surgical treatment plans of a variety of other ... dermaka cream is very effective for bruising and causes a rapid resolution of bruising ...
(Date:6/24/2016)... ... June 24, 2016 , ... Dr. Seema Daulat, a native Texan and University ... Lamar location as of July 13, 2016. , Dr. Daulat earned her Doctorate of ... she regularly volunteered at the Agape Clinic serving Dallas’ underprivileged community. , Following medical ...
(Date:6/23/2016)... ... 23, 2016 , ... SyncDog, Inc. , the leading ... is featured in the current issue of Silicon Review magazine. Silicon ... technology solutions and features them in their magazine. The magazine allows top-level executives ...
(Date:6/23/2016)... ... 23, 2016 , ... The U.S. Supreme Court decision on immigration has significant ... The Senior Citizens League (TSCL) . “President Obama’s executive actions on immigration would ... who worked in this country illegally, even though the newly - issued green cards ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... 2016  Arkis BioSciences, a leading innovator in ... durable cerebrospinal fluid treatments, today announced it has ... is led by Innova Memphis, followed by Angel ... investors.  Arkis, new financing will accelerate the commercialization ... release of its in-licensed Endexo® technology. ...
(Date:6/23/2016)... BEVERLY HILLS, Calif. , June 23, 2016 ... faced the many challenges of the current process. Many of ... option because of the technical difficulties and high laboratory costs ... would have to offer it at such a high cost ... to afford it. Dr. Parsa Zadeh , ...
(Date:6/23/2016)... 2016 Roche (SIX: RO, ROG; OTCQX: RHHBY) ... Elecsys BRAHMS PCT (procalcitonin) assay as a dedicated testing ... With this clearance, Roche is the first IVD company ... for sepsis risk assessment and management. PCT ... PCT levels in blood can aid clinicians in assessing ...
Breaking Medicine Technology: